Hardt W - Search Results

1

Hardt W, Schmidt-Gollwitzer M, Horowski R. Hardt W, et al. Gynecol Obstet Invest. 1979;10(2-3):95-105. doi: 10.1159/000299923. Gynecol Obstet Invest. 1979. PMID: 535777 Clinical Trial.

2

[The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].

Schmidt-Gollwitzer M, Hardt W, Schmidt-Gollwitzer K, Michel E, Nevinny-Stickel J. Schmidt-Gollwitzer M, et al. Among authors: hardt w. Geburtshilfe Frauenheilkd. 1977 Jun;37(6):500-8. Geburtshilfe Frauenheilkd. 1977. PMID: 328335 Clinical Trial. German.

3

[Influence of lisuridhydrogen maleate on prolactin secretion in puerperium].

Hardt W, Schmidt-Gollwitzer M, Horowski R. Hardt W, et al. Arch Gynecol. 1979 Jul 20;228(1-4):585-6. Arch Gynecol. 1979. PMID: 485487 German. No abstract available.

4

Sustained gonadal suppression in fertile women with the LHRH agonist buserelin.

Hardt W, Schmidt-Gollwitzer M. Hardt W, et al. Clin Endocrinol (Oxf). 1983 Nov;19(5):613-7. doi: 10.1111/j.1365-2265.1983.tb00039.x. Clin Endocrinol (Oxf). 1983. PMID: 6416718

5

[Hormonal regulation mechanisms during puerperium].

Hardt W, Schmidt-Gollwitzer M, Commichau H, Nevinny-Stickel J. Hardt W, et al. Fortschr Med. 1977 Nov 24;95(44):2665-9. Fortschr Med. 1977. PMID: 924330 German.

6

Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

Borgmann V, Hardt W, Schmidt-Gollwitzer M, Adenauer H, Nagel R. Borgmann V, et al. Among authors: hardt w. Lancet. 1982 May 15;1(8281):1097-9. doi: 10.1016/s0140-6736(82)92279-6. Lancet. 1982. PMID: 6122893

7

Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.

Schmidt-Gollwitzer K, Hoebich D, Hardt W, Schuessler B, Schmidt-Gollwitzer M. Schmidt-Gollwitzer K, et al. Among authors: hardt w. Int J Fertil. 1981;26(2):86-93. Int J Fertil. 1981. PMID: 6114070

8

[The influence of long-term medication with the LH-RH analogue buserelin on the regulation of the menstrual cycle (author's transl)].

Hardt W, Schmidt-Gollwitzer M, von der Ohe M, Nevinny-Stickel J. Hardt W, et al. Geburtshilfe Frauenheilkd. 1981 Nov;41(11):791-6. doi: 10.1055/s-2008-1036992. Geburtshilfe Frauenheilkd. 1981. PMID: 6797869 German.

9

Chronic treatment with a LH-RH-agonist: a new contraceptive method?

Schmidt-Gollwitzer M, Hardt W, Schmidt-Gollwitzer K, Nevinny-Stickel J. Schmidt-Gollwitzer M, et al. Among authors: hardt w. Acta Eur Fertil. 1981 Sep;12(3):275-6. Acta Eur Fertil. 1981. PMID: 6803498

10

[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].

Hardt W, Schmidt-Gollwitzer K, Nevinny-Stickel J, Schmidt-Gollwitzer M. Hardt W, et al. Geburtshilfe Frauenheilkd. 1982 Dec;42(12):874-7. doi: 10.1055/s-2008-1037177. Geburtshilfe Frauenheilkd. 1982. PMID: 6819180 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters